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Context: During the periimplantation period, human chorionic gonadotropin (hCG) plays a key
role by increasing the uterine blood flow through uterine vessel vasodilatation but also through
angiogenesis. Indeed, we previously demonstrated that hCG contributes to endothelial cell re-
cruitment and vessel formation.
Objective: In this study, hCG was proposed as an arteriogenic factor that could promote perivas-
cular cell recruitment and vessel stabilization.
Design: The aortic ring assay, a three-dimensional ex vivo angiogenesis system mimicking all the
steps of the angiogenesis processwas used to study the impact of hCGon pericyte recruitment and
vessel maturation.
Setting: The study was conducted at a university hospital laboratory.
Main Outcome Measures: Perivascular cell proliferation, migration, and apposition were quanti-
fied by computerized image analysis.
Results: Physiological concentrations of hCG (10–400 IU/ml) significantly enhanced pericyte
sprouting and migration and gave rise to the maturation and coverage of endothelial capil-
laries. In a three-dimensional coculture model of endothelial and perivascular cells, hCG en-
hanced vessel tube formation and endothelial/mural cell adhesion. In addition, hCG stimulated
the proliferation of human umbilical vein endothelial cells and smooth muscle cells. The spec-
ificity of these effects was determined by using an anti-hCG blocking antibody. Signaling
pathways implicated on this hCG effect is protein kinase A and phospholipase C/protein kinase
C dependent for the proliferative effect but only phospholipase C/protein kinase C for the
migrative process.
Conclusions:Our findings highlight a novel paracrine role of this early embryonic signal in vessel
maturation by stimulating perivascular cell recruitment, migration, and proliferation. (J Clin
Endocrinol Metab 94: 4567–4574, 2009)
Peritrophoblastic angiogenesis at the implantation site isan important step for successful pregnancy.Among the
widerangeofcontributinghormones, cytokines,andgrowth
factors, human chorionic gonadotropin (hCG) plays a key
role and modulates: 1) the implantation process by control-
ling leukemia inhibitory factorandmacrophagecolonystim-
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ulating factor release, 2) tissue remodeling by increasingma-
trixmetalloproteinase-9 production, and 3) angiogenesis by
inducing vascular endothelial growth factor (VEGF) up-reg-
ulation (1, 2). LH/hCG receptor (LH/hCGR) was first de-
scribed on endometrial and myometrial vascular smooth
muscle cells and thereafter in vascular endothelial cells (ECs)
of the uterine vessels (3, 4). In vivo administration of hCG
reducedvascularresistance inhumanuterusanddecreased in
vitro the formationofvasoconstrictor eicosanoidsof thevas-
cular wall (4, 5). Zygmunt et al (6). showed that hCG was
able to promote angiogenesis by stimulating EC migration
and capillary sprout formation. We previously showed that
the angiogenic activity of hCG is mediated through a direct
effect onECsand throughaparacrinedialoguebetweenECs
and endometrial epithelial cells (1). UponhCGbinding to its
LH/hCGR at the surface of endometrial ECs, VEGF synthe-
sis and secretion is up-regulated, thereby activating the an-
giogenic switch in ECs. The endometrial epithelium is thus
sensitive to specific embryonic signals, leading to the pro-
duction of VEGF, the main angiogenic factor (7). As classi-
cally observed in pathological conditions (8), VEGF-driven
angiogenesis results in the formationofhighlyabnormal ves-
sels deficient in mural/pericyte coverage. The putative effect
of hCG on perivascular cell recruitment and hence on vessel
maturation is currently unknown. To address this issue, we
used in this study the aortic ring assay, which mimics the
different steps of the angiogenic process including EC pro-
liferation, migration, and differentiation into capillaries (9).
In addition, we evaluated the effect of hCG on perivascular
cell outgrowthandECcoveragebymural cells.Theeffectsof
hCGwasalso investigated inmonoculturesandcoculturesof
ECs and smooth muscle cells (SMCs). In this study, we pro-
vide evidence for a promoting effect of hCG on vessel mat-
uration through the recruitment of perivascular cells. These
novel findings underline a much broader spectrum of activ-
ities for hCG than initially anticipated.
Materials and Methods
Materials
Reagents tested were purified urinary hCG (Pregnyl, Organon,
Roseland,NJ), recombinanthCG(Ovitrelle; Serono,Geneva, Swit-
zerland), protein kinase A (PKA) inhibitor H89 dihydrochloride
(Calbiochem, La Jolla, CA), phospholipase C (PLC) inhibitor
U73122(Calbiochem),proteinkinaseC(PKC)inhibitorbisindolyl-
maleimide I (BIM; Calbiochem), anti-hCG neutralizing antibody
(Sc-7821; Santa Cruz Biotechnology, Santa Cruz, CA), cell tracker
Green 5-chloromethylfluorescein diacetate (CMFDA; Molecular
Probes, Invitrogen, Carlsbad, CA), and CellTracker red CMRA
(Molecular Probes, Invitrogen).
Animals
Wistar rats (250 g) and C57/Bl 6 mice (10–12 wk old)
were provided by the Animal Center of the University of Lie`ge.
Experiments were conducted with the approval of the local
ethical committee for the care of experimental animals. Mice
were maintained with a 12-h light, 12-h dark cycle, with food
and water available ad libitum.
Aortic ring assay
Rat and mice aortic rings were cultured in three-dimensional
type I collagen gels as previously described (10, 11). Effects of dif-
ferent compounds were tested by addition to culture medium at d
0. For quantification, computerized image analysis was performed
onaSunSPARC30workstationwith thesoft-
ware Visilog 5.0 (Noesis, St. Aubin, France)
according toBlacher et al. (10).The following
parameters were determined: number of mi-
crovessels; maximal microvessel length, total
numberofbranching inmicrovessels,number





At d 9 of culture, aortic fragments em-
bedded in collagen gels were washed three
times in PBS for 10 min followed by a fix-
ation in 4% paraformaldehyde for 10 min.
Samples were washed again in PBS three
times for 10 min, and then nonspecific an-
tibodybindingwas blockedwithmilk 1.5%
for 20 min. Samples were incubated over-
night at room temperature with a mix of a
lectin and a primary antibody: Griffonia
Simplifolia isolectin-B4/Alexa Fluor 488 at
5 g/ml (Molecular Probes; I21411) and
rabbit anti-NG2 chondroitin sulfate pro-
FIG. 1. Effect of hCG on pericyte recruitment in the aortic ring assay. A, Photomicrographs
of aortic rings cultured in the absence (0) or presence of increasing concentrations of
recombinant hCG (rhCG; 0–100 IU/ml). Endothelial capillaries are depicted by the arrow, and
fibroblast like-cells are indicated by the dotted arrow. B, Quantification of the Nf and Fmax
(C) in response to increasing rhCG concentrations (10–400 IU/ml) after 9 d of culture. Data
are mean  SD of one representative experiment, each condition running at least four rings.
*, P  0.05; ***, P  0.001.
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teoglycan antibody (Chemicon, Temecula, CA; AB5320) at 10
g/ml.After threewashes inPBS for10min each, the tissueswere
incubatedat roomtemperaturewitha secondarygoat anti-rabbit
biotin antibody (Dako, Glostrup, Denmark; E432) at 1.9g/ml.
Finally, an incubation with streptavidin Cy3 (Sigma, St. Louis,
MO; S6402) was performed for 1 h at room temperature at 1
g/ml. Samples were mounted with Vectashield-Dapi mounting
medium (Vector Laboratories, Burlingame, CA; H-1200), after
three washes in PBS for 10 min at room temperature.
Electron transmission microscopy
Aortic three-dimensional gels culturewere stopped after 10d,
and gels were fixed 1 h at 4 C with 2.5% glutaraldehyde in a
So¨rensen 0.1 M phosphate buffer (pH 7.4). Gels were postfixed
for 30 min with 1% osmium tetroxide. After deshydratation,
samples were embedded into Epon. Ultrathin sections, obtained
with a Reichert Ultracut S ultramicrotome (Leica, Germany),
were contrasted with uranyl acetate and lead citrate. Observa-
tions were done with a Jeol 100 CX II transmission electron
microscope at 60 kV (Peabody, MA).
Cell culture
Human umbilical vein endothelial cells (HUVECs) were
grown on 0.2% gelatin-coated dishes in MCDB 131 medium
(Life Technologies, Inc., Carlsbad, CA) supplementedwith 10%
fetal bovine serum (FBS), HEPES (25 mM), glutamine (2 mM),
endothelial cell growth supplement (12 ng/ml; BD Biosciences,
Bedford, MA), heparin (2.5 mg/ml), and antibiotics (penicillin-
streptomycin, 100U/ml); for experiments, cells at passages 2–10
were used. Human aortic SMCs (AoSMC) purchased from
Lonza (Basel, Switzerland; CC-2671) were grown in complete
smooth muscle medium containing 10% FBS (SmBm; Lonza;
CC-3181). Cells were at passages 6–10 used for experiments.
Mouse SMCs C3H/10T1/2, clone 8 cell line (American Type
Culture Collection, Manassas, VA; CCL-226) were grown in
basal medium (Life Technologies, Inc.) supplemented with 10%
fetal calf serum, glutamine (2 mM), penicillin/streptomycin (100
g/ml), HEPES (15 mM), and bicarbonate. All cell types were
cultured in 5% CO2 at 37 C, and media were replaced every 2 d.
10 T1/2 cell migration
Toevaluate SMCmigration, thewoundassaymodelwasused
as described by Savani et al. (12). 10 T1/2 cells (105) were seeded
on 24-well microplates and grown overnight in 10% FBS basal
medium.A cross-shape scratchwasmadewith a tip in cellmono-
layers. After 4 and 9 h, pictures were acquired at the same mag-
nification and location in the bottom of the dish. Quantification
was done using ImageJ software (National Institutes of Health,
Bethesda, MD) by measurements of wounded areas at time 0, 4,
and 9 h.
Proliferation assays
Proliferation testswere performedonAoSMCs, 10T1/2 cells,
and HUVECs cultured for 24 h. Cells (5 103) were seeded and
allowed to adhere in 96-well microplates. For HUVEC prolifer-
ation, 96-well microplates were coated with gelatin at 2 mg/ml.
Cells were treated with or without hCG (10–1000 U/ml), H89
(10 M), U73122 (10 M), or BIM (1 g/ml) alone or combined
with hCG (100 IU/ml) in their respective culture media contain-
ing 2% FBS. Cell proliferation was evaluated using 5-bromo-
2-deoxyuridine incorporation into cells followed by a cell pro-
liferation colorimetric assay (Roche Applied Science, Penzberg,
Germany) as previously described (13).
Boyden chamber migration assay
AoSMC cell migration was assessed using Boyden chamber
assay. Cells were seeded on top of polycarbonate filters (8 m
pore) of Transwell Permeable Support (Costar, Corning Inc.,
Lowell, MA). Cells in stock culture were trypsinized, suspended
in serum-free medium containing 0.1% BSA, and placed on the
upper compartmentof the chamber (7.104 cells/filter). The lower
compartment of the chamberwas filledwith serum-freemedium
containing 1% BSA, supplemented with or without hCG, anti-
hCG,H89,U73122, andBIM.After an incubationperiodof24h
at 37 C, filters were fixed in methanol. Cells on filters were
stained with crystal violet solution 0.1% (Sigma). Nonmigrated
FIG. 2. Effect of hCG on pericyte outgrowth from the aortic rings. A
and B, Photomicrographs of aortic rings cultured in the absence
(control) (A, C, E, and G) or presence of uhCG 100 IU/ml (B, D, F, and
H) (n  5 rings per condition). Whole-mount double immunostainings
of the collagen gels at d 9 of culture with an anti-EC-specific isolectin
(IB4) in green and a pericyte-specific antibody (NG2) in red; nuclei were
counterstained with 4,6-diamino-2-phenylindole (blue) (C–F).
Representative electron micrographs (G) showing a section of
immature nude endothelial tubes composed of ECs (E) delimiting a
lumen (L) and a mature endothelial tube (H) composed of endothelial
cells (E) delimiting a larger lumen (L) and surrounded by a perivascular
cell (P).
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cells at the upper surface of the filters were wiped away with a
cotton swab. Quantification of the migration assay was done by
colorimetric measurement (  560 nm) of cells at the lower
surface of the filter.
HUVEC and AoSMC coculture assays
AoSMC and HUVEC coculture assays were performed in a
modified matrigel overlay assay as previously reported (14).
Briefly, HUVEC cells (15  103 CMFDA green labeled cells)
were seeded on top of a 300 l matrigel layer (15) in 24-well
microplates and allowed to form tubular structures. Six hours
later, AoSMCs (15  103 CMRA red labeled) were overseeded
on HUVECs, and 100 IU/ml hCG were added or not. After 24 h,
cultures were stopped, rinsedwith PBS, and fixedwith 4%para-
formaldehyde until microscopic examination. To analyze the
AoSMC distribution around the EC tube network, an original
computer-assisted quantification was developed by implementing
an algorithm using the image analysis tool box of MATLAB7.1
software (The Mathworks, Natick, MA). This method calcu-
lated the smallest distance separating green pixel corresponding
to EC and red pixel corresponding to AoSMCs identified by
cell tracker green CMFDA and CellTracker red CMRA,
respectively.
Statistical analyses
Statistical analysis were conducted with GraphPad Prism
software (GraphPad Inc., La Jolla,CA).Aortic rings experiments
including four explants per condition were
repeated at least twice. Student’s t test was
used to evaluatewhether differences among
groups were significant. For computerized
image analysis, statistical analysis were
performed with the statistics toolbox of
MATLAB 7.1 (MathWorks) using Stu-
dent’s t test or using Wilcoxon test, with
regard to heteroscedasticity. In the other ex-
periments, Mann-Whitney tests were used
for statistical analysis. P  0.05 was con-
sidered as statistically significant.
Results
hCG promotes perivascular cell
recruitment in the aortic ring
assay
According to our previous results
(1), the incubation of rat aortic frag-
ments embedded in a collagen gel with
recombinant hCG induced an angio-
genic response characterized by en-
hanced capillary formation (Fig. 1. A).
Interestingly, dispersed cells spread
out, suggesting a possible mobilization
of perivascular cells in addition to that
of EC. These cells have been quantified
through a computerized quantification
(10) and were identified as mural cells
by immunostaining. The addition of
hCG (10–400 IU/ml) to the aortic ring culture media re-
sulted in an increase of Nf (Fig. 1B) and distance of cell
migration from the aortic explant (Fmax) (Fig. 1C). Sim-
ilar results were obtained with urinary hCG. For next ex-
periments, urinary hCG (uhCG) was used at its optimal
concentration (100 IU/ml).
Whole-mount immunostainings ofmice aortic ring cul-
tures (d 9 of culture) were performed to identify the ECs
through Isolectin B4 staining and pericytes through NG2
detection. They revealed the pericyte phenotype of
perivascular cells that were growing out in the presence of
stimulatory dose of hCG (100 IU/ml) (Fig. 2). In control
conditions, in the absence of hCG, two types of capillary-
like structures were detected, one composed of naked en-
dothelial cells and the other one composed of pericytes
(Fig. 2, C and E). In sharp contrast, on hCG treatment,
pericyte proliferation andmigrationwere drastically stim-
ulated (Fig. 2D), and endothelial tubes displayed amature
phenotype with a pericyte coating (Fig. 2, F and H). Ob-
servationsbyelectron transmissionmicroscopyconfirmed
the presence of perivascular cells upon treatment with
hCG (Fig. 2H). In sharp contrast, in the absence of hCG,
FIG. 3. Effect of hCG on EC-pericyte interactions in a three-dimensional matrigel coculture
model. A, Photomicrographs (scale bars, 100 m) of HUVECs (green labeled) and AoSMCs
(red-labeled) after 12 h of coculture without (ctrl) or with uhCG (100 IU/ml hCG). Arrows
point area in which AoSMCs are close to endothelial tube-like structures. B, Computer-
assisted quantification of AoSMC distribution around HUVEC tube network. Upon hCG
treatment, pericytes were closer to ECs (blue curve). The Student t test was used for statistical
analysis (n  20). **, P  0.05.
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capillaries were formed of a single layer of naked ECs
delimiting a lumen (Fig. 2G).
hCG promotes EC and SMC interactions in a
three-dimensional in vitro coculture model of
HUVECs and human AoSMCs
The interactions between EC and human AoSMCs
were then investigated in vitro in a coculture system on
matrigel. When HUVECs were seeded on matrigel, they
organized into tube-like structures. AoSMCs were then
seeded on top of the HUVEC culture to study pericyte-
endothelial cell interactions (Fig. 3). Under hCG treat-
ment, pericytes became more closely apposed to the ECs
(Fig. 3A). An original computer-assisted method of quan-
tification was used to measure the distance separating
pericytes from ECs (Fig. 3B). The density of mural cells
apposed to ECs (distance5 M) was 20% higher under
hCG treatment (**,P0.05) (Fig. 3B).
In contrast, the density of mural cells
present at a distance higher than 50m
from ECs was 1.5-fold lower on hCG
treatment (**, P  0.05).
hCG promotes SMC and EC
proliferation through PKA/PKC
signaling pathways
We previously reported that hCG
can directly modulate the proliferation
of ECs (1). To evaluate the putative di-
rect effect of hCG on perivascular cells,
we next determined the impact of hCG
on the proliferation of human AoSMCs.
Increasing concentrations of hCG (10–
500 IU/ml) stimulated AoSMC prolifer-
ation in a dose-dependent manner (Fig.
4A). This dose-response curve displayed
a bell shape with maximal effect of hCG
between 50 and 100 IU/ml. Similar re-
sults were obtained by using murine
smooth muscle cells (10 T1/2) (Fig. 4B).
The specificity of this effect was assessed
by the addition of an anti-hCG-blocking
antibody together with hCG (Fig. 4C).
Cell signaling pathways involved
in the proliferative effects exerted by
hCG on ECs and SMCs have next
been investigated by inhibiting differ-
ent pathways putatively involved in
LH/hCGR signaling (Fig. 4, D and E).
Addition of a PKC inhibitor (1 g/ml
BIM) and a PLC inhibitor (10 M
U73122) abolished the effect of hCG
on HUVEC proliferation (Fig. 4D).
Addition of a PKA inhibitor (10 M H89) and a PLC
inhibitor (10 M U73122) abolished the effect of hCG
on AoSMCs (Fig. 4E).
hCG induces SMC migration
A wound healing in vitro assay was first applied to
determine the effect of hCG on SMCs (10T1/2). Recolo-
nization of wounded areas was evaluated after 4 and 9 h
by measuring the width of the gap in the same areas. At
each time point, the size of the gap was measured, nor-
malized to each native wound surface (time 0) and data
were averaged (n  24). Already after 4 h, hCG induced
cell migration at a higher extent than in control condition
(Fig. 5, A and B). After 9 h the recolonization was in-
creased 1.4-fold (Fig. 5, A and B). A Boyden migration
chamber assay was next used to further determine the
promigratory effect of hCG on both smooth muscle cells
FIG. 4. Effect of hCG on human and murine SMC proliferation. Proliferation of AoSMCs
treated for 24 h with 10–500 IU/ml uhCG (A) and 10 T1/2 cell line (B) were evaluated by
5-bromo-2-deoxyuridine colorimetric immunoassay. Data are expressed as means  SD (n 
10). **, P  0.01. C, Proliferation of 10 T1/2 cells treated or not with uhCG (50 IU/ml) or
anti-hCG antibody (micrograms per milliliter) for 48 h. Data are expressed as means  SD (n 
10). ***, P  0.001. D, Proliferation of HUVECs after 24 h of culture with or without uhCG
100 IU/ml, combined or not with BIM (1 g/ml) or U73122 (10 M). E, Effect of hCG (100
IU/ml), H89 (10 M), or U73122 (10 M) alone or in combination on AoSMC cell proliferation
rate. Data are expressed as means  SD (n  4). *, P  0.05; **, P  0.05; ***, P  0.001.
Results are expressed as percentage of control.
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(AoSMCs) and ECs (HUVECs). Incubations of a stimu-
latory dose of hCG (100 IU/ml) resulted in a significant
enhancement of both HUVEC (Fig. 6 A) and AoSMC mi-
gration (Fig. 6B). HUVECs and AoSMCs seeded on Boy-
den chambers filters were incubated for 24 h with hCG
(100 IU/ml) alone or in combinationwith signaling path-
way inhibitors. Whereas hCG-induced migration of
HUVECs was abolished by PKA (H89) or PLC (U73122)
inhibitor (Fig. 6C), only the PLC and PKC inhibitor (BIM)
was able to block the hCG-stimulated migration of
AoSMCs (Fig. 6, D and E). All biological effects described
above were observed in the presence of urinary and re-
combinant hCG.
Discussion
hCG is a key actor of placental vascularization (16–18),
which is one of the crucial local adaptations to successful
pregnancy. hCG stimulates directly angiogenesis through
EC recruitment, enhanced proliferation, and migration
(19). It also stimulates the release of VEGF by human
epithelial endometrial cells that causes a paracrine stim-
ulationofECs.VEGF-mediated angiogenesis results in the
formationofnaked, dilated, and leaky capillaries resulting
in tissue ischemia. Indeed, normal efficient blood circula-
tion requires the coverage of newly formed endothelial
tubes by vascular SMCs. In this study, through the use of
five different models (aortic ring, cell proliferation assay,
wound healing assay, Boyden chamber assay, and tube
formation on matrigel), we report a potent effect of re-
combinant and urinary hCG on various SMC activities
including proliferation, migration, and capacity to cover
EC capillaries.
Becauseof the complexity of themechanismunderlying
the angiogenic reaction and vessel maturation through
pericyte recruitment, apanelof complementarymodels (9)
has been used to investigate the mechanisms of action of
hCG. The aortic ring assay comprises three different cell
types (ECs, fibroblastic cells, and SMCs) and mimics four
steps of the angiogenic process: 1) EC proliferation, 2) EC
migration, 3) EC differentiation into capillaries, and 4)
maturation by pericyte coverage (20). hCG was able to
enhance the sprouting of both IB4-positive EC and NG2-
positive pericytes. Interestingly, both their number and
distance of migration were stimulated on hCG treatment.
Of great interest is the finding that hCG promoted the
coverage of endothelial capillaries bypericytes,whereas in
its absence, EC and pericytes spread out in an independent
manner. The impact of hCGonEC/mural cell interactions
was then confirmed in a three-dimensional coculture
model leading to tube-like structure formation. When EC
and pericytes were cocultured on matrigel, hCG stimu-
lated an affixing of close pericytes to ECs, which mimics
the vascular maturation process. Our data are in accor-
dance with clinical observations performed on hCG-res-
cued human corpus luteum. Indeed, hCG treatment of
women increased endothelial cell proliferation and peri-
cyte recruitment indicating an increase rate of angiogen-
esis together with vessel stabilization (21).
The presence of LH/hCGRs has been evidenced in vivo
in the endothelium and smooth muscle of uterine blood
vessels. Their expression levels are significantly increased
in the intramyometrial segment (3, 4). In line with these
findings, immunostaining of LH/hCGR revealed positiv-
ity on AoSMCs (data not shown). Our previous work re-
ported that hCGhas a direct stimulating effect on ECs (1).
Accordingly, vascular uterine endothelial cells expressing
LH/hCGR responded to physiological doses of hCG with
increased capillary formation in vitro (6). The LH/hCGR-
dependent effect of hCG is further supported by the ap-
plicationof theaortic ringassay toLH/hCG-deficientmice
(22). This genetic approach clearly demonstrated an ab-
rogation of hCG angiostimulation in the absence of
LH/hCGR.
To further dissect the mechanism of hCG action, more
simple models consisting of monocultures of EC or peri-
cytes/SMCs were used to determine whether hCG can ex-
ert an effect on cell proliferation and/or cell migration.
hCG induced a strong proliferative effect on both ECs and
FIG. 5. Effect of hCG on SMC migration in a wound-healing assay.
A, Photomicrographs of the wound area in 10 T1/2 cell monolayer
in a kinetic assay (at time 4 and 9 h) without (CTRL) or with
addition of uhCG 100 IU/ml to the culture medium. B,
Semiautomatic quantification of recolonized areas defined as the
primitive wound surface divided by wound surfaces persisting after
4 and 9 h. Control condition was set to 100%. Data are expressed
as means  SD (n  24). **, P  0.05; ***, P  0.001.
4572 Berndt et al. hCG and Pericytes J Clin Endocrinol Metab, November 2009, 94(11):4567–4574
SMCs from murine or human origin, which is consistent
with previous reports (23–25). Blocking antibody addi-
tion and use of recombinant hCG further confirmed the
specificity of this effect. This effect was dose dependent
with an optimal effect at 50–100 IU/ml corresponding to
the physiological hCG concentration achieved in the first
2 wk of pregnancy. Such hCG concentration has proven a
similar optimal angiogenic response in terms of endothe-
lial cell proliferation and sprouting in different in vitro
models (1, 19) and led to a stimulation of trophoblast
migration in vitro (26).
We previously reported that hCG-mediated prolifera-
tive effectwas PKAdependent (1). In the present study,we
provide additional data that the stimulation of HUVEC
proliferation by hCG is also sensitive to PKC and PLC
inhibition.AoSMCproliferationwas affected by PKAand
PLC pathway inhibitions under hCG treatment. This is in
line with previous reports showing that in porcine myo-
metrial cells, LH/hCGR activation is coupled with two
different signaling systems: adenylate cyclase and PLC (27).
SMC-inducedmigrationwas further
studied in a wound healing assay in
which hCG enhanced 10T1/2 migra-
tion already after 4 h of treatment and
further after 9 h. This early promigra-
tive effect signed a direct effect on mi-
gration property andwas not reflecting
an enhancement of cell proliferation in
the wounded area. hCG caused a 2.5-
fold increase of AoSMC migration in a
Boyden chamber assay and a 2-fold in-
crease ofHUVECmigration. The effect
of hCG on EC migration was clearly
more potent when uterine microvascu-
lar endothelial cells were used (6). The
present study demonstrates for the first
time that hCG enhances pericyte/
SMC migration. To specify the signal-
ing pathways involved in this process,
PKA and PLC inhibitors were tested in
combination or not with hCG in the
Boyden chambers model. We demon-
strated that HUVEC-hCG induced mi-
gration signals through PKA and PLC
pathways, whereas it involves only the
PLC pathway in AoSMCs. Interest-
ingly, this suggests that the signaling
pathways involved in hCG’s promigra-
tive property are cell type dependent.
In summary, our results support the
complex and key role played by hCG in
the angiogenic process occurring at the
implantation site. They provide evidence for a novel func-
tion of hCG in vessel maturation through the stimulation
of pericyte recruitment.
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FIG. 6. Effect of hCG on HUVEC and AoSMC migration in a Boyden chamber assay.
Migration of HUVECs (A) or AoSMCs (B) in the absence or presence of uhCG 100 IU/ml.
HUVECs (C) and AoSMCs (D) were treated or not with uhCG 100 IU/ml, H89 (10 M), or
U73122 (10 M) alone or in combination. Inhibition of hCG-induced migration by PKC
inhibitor (BIM) (E). Data are (means  SD) expressed as percentage of control condition (n 
4). *, P  0.05; **, P  0.05; ***, P  0.001.
J Clin Endocrinol Metab, November 2009, 94(11):4567–4574 jcem.endojournals.org 4573
References
1. Berndt S, Perrier d’Hauterive S, Blacher S, Pe´queux C, Lorquet S,
Munaut C, ApplanatM,Herve´MA, Lamande´ N, Corvol P, van den
Bruˆle F, Frankenne F, Poutanen M, Huhtaniemi I, Geenen V, Noe¨l
A, Foidart JM 2006 Angiogenic activity of human chorionic gonad-
otropin throughLHreceptor activationonendothelial andepithelial
cells of the endometrium. FASEB J 20:2630–2632
2. Licht P, Russu V, Lehmeyer S, Mo¨ll J, Siebzehnru¨bl E, Wildt L 2002
Intrauterine microdialysis reveals cycle-dependent regulation of en-
dometrial insulin-like growth factor binding protein-1 secretion by
human chorionic gonadotropin. Fertil Steril 78:252–258
3. Lei ZM, Reshef E, Rao V 1992 The expression of human chorionic
gonadotropin/luteinizing hormone receptors in human endometrial
andmyometrial bloodvessels. JClinEndocrinolMetab75:651–659
4. Toth P, Li X, Rao CV, Lincoln SR, Sanfilippo JS, Spinnato 2nd JA,
Yussman MA 1994 Expression of functional human chorionic go-
nadotropin/human luteinizing hormone receptor gene in human
uterine arteries. J Clin Endocrinol Metab 79:307–315
5. Toth P, Lukacs H, Gimes G, Sebestyen A, Pasztor N, Paulin F, Rao
CV 2001 Clinical importance of vascular LH/hCG receptors—a re-
view. Reprod Biol 1:5–11
6. ZygmuntM,Herr F, Keller-Schoenwetter S, Kunzi-RappK,Mu¨nstedt
K, Rao CV, Lang U, Preissner KT 2002 Characterization of human
chorionic gonadotropin as a novel angiogenic factor. JClinEndocrinol
Metab 87:5290–5296
7. Ferrara N, Gerber HP, LeCouter J 2003 The biology of VEGF and
its receptors. Nat Med 9:669–676
8. Carmeliet P 2003 Angiogenesis in health and disease. Nat Med
9:653–660
9. Berndt S, Bruye`re F, JostM,NoelA2008 In vitro and in vivomodels
of angiogenesis to dissect MMP functions. Edwards D, Hoyer-
Hansen G, Blasi F, Sloane BF, eds. The cancer degradome. Pro-
teases and cancer biology. New York: Springer; 303–323
10. Blacher S, Devy L, Burbridge MF, Roland G, Tucker G, Noe¨l A,
Foidart JM 2001 Improved quantification of angiogenesis in the rat
aortic ring assay. Angiogenesis 4:133–142
11. Masson V, Devy L, Grignet-Debrus C, Bernt S, Bajou K, Blacher S,
Roland G, Chang Y, Fong T, Carmeliet P, Foidart JM, Noe¨l A 2002
Mouse Aortic Ring Assay: A New Approach of the Molecular Ge-
netics of Angiogenesis. Biol Proced Online 4:24–31
12. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN,
Stern R, Nance DM, Turley EA 1995 Migration of bovine aortic
smooth muscle cells after wounding injury. The role of hyaluronan
and RHAMM. J Clin Invest 95:1158–1168
13. Perrier d’Hauterive S,Charlet-RenardC,Berndt S,DuboisM,Munaut
C,Goffin F,HagelsteinMT,Noe¨l A,HazoutA, Foidart JM,GeenenV
2004 Human chorionic gonadotropin and growth factors at the em-
bryonic-endometrial interface control leukemia inhibitory factor (LIF)
and interleukin 6 (IL-6) secretion by human endometrial epithelium.
Hum Reprod 19:2633–2643
14. SaundersWB, Bohnsack BL, Faske JB, Anthis NJ, Bayless KJ, Hirschi
KK, Davis GE 2006 Coregulation of vascular tube stabilization by
endothelial cell TIMP-2andpericyteTIMP-3. JCell Biol 175:179–191
15. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR
1979 Laminin—a glycoprotein from basement membranes. J Biol
Chem 254:9933–9937
16. Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD 2003 Angio-
genesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Re-
prod Biol 110(Suppl 1):S10–S18
17. Licht P, Russu V, Wildt L 2001 On the role of human chorionic
gonadotropin (hCG) in the embryo-endometrialmicroenvironment:
implications for differentiation and implantation. Semin Reprod
Med 19:37–47
18. Licht P, Fluhr H, Neuwinger J, Wallwiener D, Wildt L 2007 Is
humanchorionic gonadotropindirectly involved in the regulationof
human implantation? Mol Cell Endocrinol 269:85–92
19. Herr F, Baal N, Reisinger K, Lorenz A, McKinnon T, Preissner KT,
Zygmunt M 2007 HCG in the regulation of placental angiogenesis.
Results of an in vitro study. Placenta 28(Suppl A):S85–S93
20. Nicosia RF, Ottinetti A 1990 Growth of microvessels in serum-free
matrix culture of rat aorta. A quantitative assay of angiogenesis in
vitro. Lab Invest 63:115–122
21. Wulff C, Dickson SE, Duncan WC, Fraser HM 2001 Angiogenesis
in the human corpus luteum: simulated early pregnancy by HCG
treatment is associated with both angiogenesis and vessel stabiliza-
tion. Hum Reprod 16:2515–2524
22. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I 2001 Normal
prenatal but arrested postnatal sexual development of luteinizing
hormone receptor knockout (LuRKO) mice. Mol Endocrinol 15:
172–183
23. Ko¨rnyei JL, Lei ZM, Rao CV 1993 Human myometrial smooth
muscle cells are novel targets of direct regulation by human chori-
onic gonadotropin. Biol Reprod 49:1149–1157
24. Lee TK, Kim DI, Song YL, Lee YC, Kim HM, Kim CH 2004 Dif-
ferential inhibition of Scutellaria barbata D. Don (Lamiaceae) on
HCG-promoted proliferation of cultured uterine leiomyomal and
myometrial smooth muscle cells. Immunopharmacol Immunotoxi-
col 26:329–342
25. Horiuchi A,NikaidoT,YoshizawaT, ItohK,Kobayashi Y,TokiT,
Konishi I, Fujii S 2000 HCG promotes proliferation of uterine
leiomyomal cells more strongly than that of myometrial smooth
muscle cells in vitro. Mol Hum Reprod 6:523–528
26. Zygmunt M, McKinnon T, Herr F, Lala PK, Han VK 2005 HCG
increases trophoblastmigration in vitro via the insulin-like growth fac-
tor-II/mannose-6 phosphate receptor. Mol Hum Reprod 11:261–267
27. Kisielewska J, Flint AP, Ziecik AJ 1996 Phospholipase C and ade-
nylate cyclase signalling systems in the action of hCG on porcine
myometrial smooth muscle cells. J Endocrinol 148:175–180
4574 Berndt et al. hCG and Pericytes J Clin Endocrinol Metab, November 2009, 94(11):4567–4574
